MedTrace Logo

Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

NCT03676400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2019-08-12

No results posted yet for this study

Summary

The purpose of this study is to assess whether cosmetic investigational product containing NGF-574H is safe and effective in the treatment of androgenic alopecia in asian adults.

Conditions

  • Androgenic Alopecia

Interventions

OTHER

conditioned media of umbilical cord blood-derived stem cells

Hair serum with 5% conditioned media of human umbilical cord blood-derived mesenchymal stem cells

OTHER

Placebo

Hair serum without conditioned media of human umbilical cord blood-derived mesenchymal stem cells

Sponsors & Collaborators

  • Medipost Co Ltd.

    lead INDUSTRY

Principal Investigators

  • Byungcheol PARK, MD · Dankook University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-02
Primary Completion
2019-07-22
Completion
2019-07-24

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03676400 on ClinicalTrials.gov